There is strong evidence that mutations of splicing components SRSF2 and SF3B1 cause cancer in part by enhancing the inclusion of pseudoexons with in-frame stop codons for two genes EZH2 and BRD9, respectively, [34–36]. This evidence concerns the gene EZH2 and cancer.